The Pandemic Hits Us Hard, but We Don’t Lose Hope

At the end of 2019, we faced a new variant of the coronavirus that can cause pneumonia and acute respiratory distress syndrome-like symptoms. It started in Wuhan, Hubei Province, China, and spread quickly to the whole world.This new virus is called Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and can manifest as a disease called coronavirus disease 2019 (COVID-19). On March 13th, 2020 World Health Organization (WHO) declared COVID-19 as a global pandemic, and the story of frightening pandemic begin.

Download Full-text

Multiorgan Involvement in COVID-19 and Possible Therapies

Journal of Cardiac Critical Care TSS ◽

10.1055/s-0040-1714151 ◽

2020 ◽

Vol 04 (01) ◽

pp. 20-24

Author(s):

Prachee Sathe ◽

Vijay Sundar Singh

Keyword(s):

Acute Respiratory Distress Syndrome ◽

Respiratory Distress Syndrome ◽

Respiratory Distress ◽

World Health Organization ◽

Distress Syndrome ◽

Respiratory Illness ◽

World Health ◽

The World ◽

Novel Coronavirus ◽

Health Organization

AbstractIn late 2019, China reported cases of respiratory illness in humans, which involved a novel Coronavirus SARS-CoV-2 (also known as 2019-nCoV). The World Health Organization (WHO) termed the disease COVID-19 (i.e., Coronavirus disease 2019). Most of the morbidity and mortality from COVID-19 is largely due to acute viral pneumonitis that leads to acute respiratory distress syndrome (ARDS). This article will discuss the clinical features of the multiorgan involvement in COVID-19 as well as the management of patients who become critically ill due to COVID-19.

Download Full-text

Salivary Diagnosis of COVID-19

Pakistan Armed Forces Medical Journal ◽

10.51253/pafmj.v71i6.5498 ◽

2022 ◽

Vol 71 (6) ◽

pp. 2254-55

Author(s):

Seema Shafiq ◽

Asim Riaz

Keyword(s):

Acute Respiratory Distress Syndrome ◽

Severe Acute Respiratory Syndrome ◽

Respiratory Distress Syndrome ◽

Respiratory Distress ◽

Sore Throat ◽

Distress Syndrome ◽

Signs And Symptoms ◽

Fatality Rate ◽

Ongoing Research ◽

Global Pandemic

Dear Editor, It is indeed an honour for us to contribute towards the ongoing research regarding the latest contagion, Coronavirus disease (COVID-19) as caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leading to global pandemic with variable clinical outcomes. COVID-19 positive individuals present with a variety of signs and symptoms as sore throat, cough, fever, dyspnoea, headache, myalgia, nausea, and vomiting whereas, some develop severe acute respiratory distress syndrome with a fatality rate of about 10%.1 Possible oral findings include xerostomia, hypogeusia, and chemosensory alterations. Common routes of transmission being person-to-person via direct sneeze, cough, and droplet inhalation or by contact through mucosa of eyes, nose and saliva.

Download Full-text

Pathomorphological Changes In The Lungs Of COVID-19 Patients

Journal of Asian Medical Students' Association ◽

10.52629/jamsa.v9i1.259 ◽

2021 ◽

Vol 9 (1) ◽

Author(s):

Zeshan Ali

Keyword(s):

Acute Respiratory Distress Syndrome ◽

Respiratory Failure ◽

Respiratory Distress Syndrome ◽

Respiratory Distress ◽

Distress Syndrome ◽

Multiple Organ ◽

World Health ◽

Severe Respiratory Failure ◽

Novel Virus ◽

Health Organization

In December 2019, a novel virus was discovered in China causing severe acute respiratory distress syndrome and the virus was designated as SARS-CoV-2 [1]. On 11th March 2020, the Corona Virus (SARS-CoV-2) was declared a pandemic by World Health Organization (WHO) [2]. Millions of people worldwide have been affected by this virus [3]. Most of the patients shows mild symptoms. Severe cases lead to the death of patients due to severe respiratory failure. Multiple organ failure has been seen in many patients suffering from COVID-19

Download Full-text

Extracorporeal Membrane Oxygenation for COVID-19: Case Report of Nine Patients

Frontiers in Medicine ◽

10.3389/fmed.2021.697338 ◽

2021 ◽

Vol 8 ◽

Author(s):

Jing Hua ◽

Xin Zhang ◽

Na Wang ◽

Linyu Ran ◽

Shengyun Wang ◽

...

Keyword(s):

Acute Respiratory Distress Syndrome ◽

Extracorporeal Membrane Oxygenation ◽

Respiratory Distress Syndrome ◽

Respiratory Distress ◽

Distress Syndrome ◽

World Health ◽

Randomized Controlled ◽

Membrane Oxygenation ◽

Health Organization ◽

Larger Sample

Covid-19, Coronavirus disease 2019; ARDS, Acute respiratory distress syndrome; ECMO, Extracorporeal Membrane Oxygenation; WHO, World Health Organization; ICUs, Intensive care units. Acute respiratory distress syndrome (ARDS) is a fatal comorbidity of critically ill patients with COVID-19, who often end up on respiratory support. However, the safety and effectiveness of Extracorporeal Membrane Oxygenation (ECMO) in the treatment of COVID-19 remains to be elucidated at present. Here, we report on nine patients who received ECMO due to severe SARS-CoV-2 infection in Wuhan, China. Our initial experiences suggest that carefully selecting patients, as well as management by a well-trained team, are critical to implementing ECMO in patients with COVID-19. More randomized controlled trials with larger sample sizes are needed to evaluate the usefulness of ECMO in patients with COVID-19.

Download Full-text

ASUPAN GIZI SEIMBANG TINGKATKAN IMUNITAS TUBUH SAAT PANDEMI COVID-19

Prosiding SENAPENMAS ◽

10.24912/psenapenmas.v0i0.15034 ◽

2021 ◽

pp. 503

Author(s):

Alexander Halim Santoso ◽

Sung Chian

Keyword(s):

Acute Respiratory Distress Syndrome ◽

Severe Acute Respiratory Syndrome ◽

Respiratory Distress Syndrome ◽

Respiratory Distress ◽

Distress Syndrome ◽

Close Contact ◽

Severe Pneumonia ◽

Learning System ◽

World Health ◽

Prevention Measures

Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by the Coronavirus of the genus Severe Acute Respiratory Syndrome Human Corona virus (SARS-HCoV). Transmission of this disease occurs through close contact, especially through respiratory droplets when the patient coughs or sneezes. Most people with this disease recover spontaneously, but some experience a fatal worsening including organ failure, septic shock, pulmonary edema, severe pneumonia and acute respiratory distress syndrome (ARDS). Breaking the chain of transmission is the key to stopping the spread of this disease. The World Health Organization, WHO, said that there are three things that can be done to prevent the spread of this disease, namely by keeping a distance, not being in a closed room, and limiting mobilization (not gathering). Increasing body immunity by implementing a clean and healthy lifestyle (PHBS) such as consuming balanced nutrition, physical activity for at least 30 minutes a day, adequate rest, utilizing traditional health are part of disease prevention measures. Changes in the learning system during the pandemic made students easily exposed to various incorrect information. Efforts are needed to explain to students to increase students' awareness of the Covid-19 disease and its prevention stepsCoronavirus Disease 2019 (COVID-19) merupakan penyakit menular yang disebabkan oleh virus Coronavirus dari genus Severe Acute Respiratory Syndrome Human Coronarvirus (SARS-HCoV). Penularan penyakit ini terjadi kontak erat terutama melalui droplets saluran napas saat penderita batuk atau bersin. Sebagian besar penderita penyakit ini sembuh secara spontan, namun beberapa mengalami perburukan yang fatal mencakup gagal organ, syok septik, edema paru-paru, pneumonia berat dan sindrom gagal napas akut (acute respiratory distress syndrome/ARDS). Pemutusan rantai penularan merupakan kunci untuk menghentikan penyebaran penyakit ini. Organisasi Kesehatan Dunia, WHO, menyampaikan ada tiga hal yang dapat dilakukan untuk mencegah penyebaran penyakit ini yaitu dengan menjaga jarak, tidak berada dalam ruangan tertutup, dan membatasi mobilisasi (tidak berkumpul). Meningkatkan daya tahan tubuh dengan menerapkan pola hidup bersih sehat (PHBS) seperti mengonsumsi gizi seimbang, beraktivitas fisik minimal 30 menit sehari, istirahat yang cukup, memanfaatkan kesehatan tradisional merupakan bagian dari langkah-langkah pencegahan penyakit. Perubahan sistem pembelajaran selama Pandemi berlangsung membuat siswa mudah terpapar dengan berbagai informasi yang tidak benar. Diperlukan upaya penjelasan pada para siswa untuk meningkatkan kesadaran para siswa terhadap penyakit Covid-19 dan langkah-langkah pencegahannya.

Download Full-text

OBESITY IN SARS-COV-2 INFECTION: LITERATURE REVIEW

10.36106/2709661 ◽

2021 ◽

pp. 19-23

Author(s):

Donizete Tavares Da Silva ◽

Priscila De Sousa Barros Lima ◽

Renato Sampaio Mello Neto ◽

Gustavo Magalhães Valente ◽

Débora Dias Cabral ◽

...

Keyword(s):

Public Health ◽

Acute Respiratory Distress Syndrome ◽

Gastrointestinal Tract ◽

Severe Acute Respiratory Syndrome ◽

Distress Syndrome ◽

Circulatory System ◽

World Health ◽

Global Public Health ◽

The World ◽

Health Organization

In March 2020, the World Health Organization (1) declared COVID-19 as a pandemic and a threat to global public health (2). The virus mainly affects the lungs and can cause acute respiratory distress syndrome (ARDS). In addition, coronavirus 2 severe acute respiratory syndrome (SARSCOV2) also has devastating effects on other important organs, including the circulatory system, brain, gastrointestinal tract, kidneys and liver

Download Full-text

Cytokine storm syndrome in SARS-CoV-2: a review

Zeitschrift für Naturforschung C ◽

10.1515/znc-2021-0062 ◽

2021 ◽

Vol 0 (0) ◽

Author(s):

Braira Wahid ◽

Noshaba Rani ◽

Muhammad Idrees

Keyword(s):

Acute Respiratory Distress Syndrome ◽

Respiratory Failure ◽

Severe Acute Respiratory Syndrome ◽

Respiratory Distress Syndrome ◽

Respiratory Distress ◽

Distress Syndrome ◽

Cytokine Storm ◽

Global Level ◽

Management Option ◽

Human Contact

Abstract After wreaking havoc on a global level with a total of 5,488,825 confirmed cases and 349,095 deaths as of May 2020, severe acute respiratory syndrome coronavirus 2 is truly living up to the expectations of a 21st-century pandemic. Since the major cause of mortality is a respiratory failure from acute respiratory distress syndrome, the only present-day management option is supportive as the transmission relies solely on human-to-human contact. Patients suffering from coronavirus disease 2019 (COVID-19) should be tested for hyper inflammation to screen those for whom immunosuppression can increases chances of survival. As more and more clinical data surfaces, it suggests patients with mild or severe cytokine storms are at greater risk of failing fatally and hence these cytokine storms should be targets for treatment in salvaging COVID-19 patients.

Download Full-text

COVID 19 and its management

Asian Journal of Pharmaceutical Research ◽

10.52711/2231-5691.2021.00022 ◽

2021 ◽

pp. 117-121

Author(s):

Subhashis Debnath ◽

Runa Chakravorty ◽

Donita Devi

Keyword(s):

Public Health ◽

Acute Respiratory Distress Syndrome ◽

Middle East ◽

Severe Acute Respiratory Syndrome ◽

Respiratory Distress Syndrome ◽

Respiratory Distress ◽

Distress Syndrome ◽

The Elderly ◽

Public Health Emergency ◽

Novel Coronavirus

In December 2019, severe acute respiratory syndrome-coronavirus-2, a novel coronavirus, initiated an outbreak of pneumonia from Wuhan in China, which rapidly spread worldwide. The outbreak was declared as “a public health emergency of international concern” by the WHO on January 30, 2020, and as a pandemic on March 11, 2020. The disease is transmitted by inhalation or contact with infected droplets and the incubation period ranges from 2 to 14 d. The symptoms are usually fever, cough, sore throat, breathlessness, fatigue, malaise among others. The disease is mild in most people; in some (usually the elderly and those with comorbidities), it may progress to pneumonia, acute respiratory distress syndrome (ARDS) and multi organ dysfunction. Many people are asymptomatic. The virus spreads faster than its two ancestors the SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), but has lower fatality.

Download Full-text